Mukherjee, Priyabrata
Mayo Clinic Graduate School of Biomedical Sciences,
United States
2025 Rank: 92,741
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Enabling & Strategic Technologies
SubField 1:
Nanoscience & Nanotechnology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 3,656 out of 156,020 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 92,741 | 106,354 |
| Total Cites | 869 | 875 |
| H-index | 16 | 16 |
| Hm-index | 4 | 4 |
| Number of Single Authored Papers | 1 | 1 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 16 | 16 |
| Total Cites to Single+First Authored Papers | 193 | 193 |
| Number of Single+First+Last Authored Papers | 56 | 56 |
| Total Cites to Single+First+Last Authored Papers | 631 | 633 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 720 | 724 |
| Ratio of Total Citations to Distinct Citing Papers | 1.21 | 1.21 |
| Self-Citation Percentage |
0.69%
|
|
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Enabling & Strategic Technologies
SubField 1:
Nanoscience & Nanotechnology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 2,664 out of 135,958 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 75,082 | 86,831 |
| Total Cites | 939 | 949 |
| H-index | 18 | 18 |
| Hm-index | 4 | 4 |
| Number of Single Authored Papers | 1 | 1 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 16 | 16 |
| Total Cites to Single+First Authored Papers | 210 | 210 |
| Number of Single+First+Last Authored Papers | 56 | 56 |
| Total Cites to Single+First+Last Authored Papers | 695 | 698 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 731 | 739 |
| Ratio of Total Citations to Distinct Citing Papers | 1.28 | 1.28 |
| Self-Citation Percentage |
1.05%
|
|
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Enabling & Strategic Technologies
SubField 1:
Nanoscience & Nanotechnology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 1,762 out of 117,692 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 53,723 | 62,896 |
| Total Cites | 1,060 | 1,071 |
| H-index | 18 | 18 |
| Hm-index | 4 | 4 |
| Number of Single Authored Papers | 1 | 1 |
| Total Cites to Single Authored Papers | 1 | 1 |
| Number of Single+First Authored Papers | 16 | 16 |
| Total Cites to Single+First Authored Papers | 249 | 251 |
| Number of Single+First+Last Authored Papers | 56 | 56 |
| Total Cites to Single+First+Last Authored Papers | 778 | 784 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 871 | 876 |
| Ratio of Total Citations to Distinct Citing Papers | 1.22 | 1.22 |
| Self-Citation Percentage |
1.03%
|
|
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Enabling & Strategic Technologies
SubField 1:
Nanoscience & Nanotechnology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 1,510 out of 103,235 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 50,896 | 57,231 |
| Total Cites | 1,137 | 1,152 |
| H-index | 19 | 20 |
| Hm-index | 5 | 5 |
| Number of Single Authored Papers | 1 | 1 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 16 | 16 |
| Total Cites to Single+First Authored Papers | 242 | 242 |
| Number of Single+First+Last Authored Papers | 56 | 56 |
| Total Cites to Single+First+Last Authored Papers | 816 | 820 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 925 | 934 |
| Ratio of Total Citations to Distinct Citing Papers | 1.23 | 1.23 |
| Self-Citation Percentage |
1.30%
|
|
Mukherjee, Priyabrata
University of Oklahoma Health Sciences Center,
United States
2021 Rank: 70,810
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Nanoscience & Nanotechnology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 1,853 out of 89,177 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 70,810 | 82,791 |
| Total Cites | 1,526 | 1,563 |
| H-index | 21 | 21 |
| Hm-index | 5 | 6 |
| Number of Single Authored Papers | 1 | 1 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 16 | 16 |
| Total Cites to Single+First Authored Papers | 301 | 301 |
| Number of Single+First+Last Authored Papers | 56 | 56 |
| Total Cites to Single+First+Last Authored Papers | 1,087 | 1,103 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 1,275 | 1,290 |
| Ratio of Total Citations to Distinct Citing Papers | 1.20 | 1.21 |
| Self-Citation Percentage |
2.37%
|
|
Mukherjee, Priyabrata
University of Oklahoma Health Sciences Center,
United States
2020 Rank: 58,696
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Nanoscience & Nanotechnology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 1,623 out of 75,210 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 58,696 | 67,254 |
| Total Cites | 1,238 | 1,284 |
| H-index | 19 | 19 |
| Hm-index | 5 | 6 |
| Number of Single Authored Papers | 1 | 1 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 16 | 16 |
| Total Cites to Single+First Authored Papers | 212 | 213 |
| Number of Single+First+Last Authored Papers | 56 | 56 |
| Total Cites to Single+First+Last Authored Papers | 894 | 917 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 1,034 | 1,052 |
| Ratio of Total Citations to Distinct Citing Papers | 1.20 | 1.22 |
| Self-Citation Percentage |
3.58%
|
|
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.